Jeremy L. Goldstein

Jeremy L. Goldstein advises compensation committees, CEOs, management teams and corporations in executive compensation and corporate governance matters, particularly as such issues arise in the context of transformative corporate events and sensitive situations. Prior Sterlington, Mr. Goldstein was a partner a Wachtell Lipton.

Mr. Goldstein has been involved in many of the largest corporate transactions of the past decade, including the pending acquisition of eviCore by Express Scripts; the acquisition of Truven Health Analytics by IBM; Westlake/Axiall; Goodrich/United Technologies; Duke Energy/Progress Energy; Oracle/BEA Systems, Inc.; Sanofi-Aventis/Genzyme; Merck/Schering Plough Corporation; The Dow Chemical Company/Rohm and Haas Company; Goldman Sachs et al./Kinder Morgan, Inc.; Verizon Wireless/ALLTEL Corporation; Goldman Sachs and TPG/ALLTEL Corporation; NYSE Group Inc./Euronext; Bank of America Corporation/MBNA Corporation; SBC Communications Inc./AT&T Corp.; Chevron Texaco Corporation/Unocal Corporation; Kmart Holding Corporation/Sears, Roebuck and Co.; Sanofi-Synthelabo SA/Aventis SA; Cingular Wireless Corporation/AT&T Wireless Services, Inc.; J.P. Morgan Chase & Co./Bank One Corporation; Bank of America Corporation/FleetBoston Financial Corp.; South African Breweries plc/Miller Brewing Company; and Phillips Petroleum Company/Conoco Inc.

Mr. Goldstein writes and speaks frequently on corporate governance and executive compensation issues and is listed as a leading executive compensation lawyer in Chambers USA Guide to America’s Leading Lawyers for Business.

Mr. Goldstein has a J.D. from New York University School of Law, an M.A. from the University of Chicago and a B.A. cum laude and with distinction in all subjects from Cornell University.